NCT06247761

Brief Summary

An RCT will be set up to compare outcomes between two groups of hand surgery patients. These are:

  • Emergency hand surgery patients - randomized to either absorbable or non-absorbable suture. The primary outcomes investigated will be:
  • Infection occurrence The secondary outcomes will be:
  • Scar appearance at 1 week and 6-8 weeks (assessed from photographs and scar scoring scale)
  • Wound inflammation as a percentage of wound length at day 7 post surgery.
  • Patient symptoms at 1 week (assessed from patient questionnaire)
  • Patient symptoms at 6-8 weeks (assessed from patient questionnaire)
  • QDASH Score at 1 week (assessed from patient questionnaire)
  • QDASH score at 6-8 weeks (assessed from patient questionnaire)
  • Occurrence of other complications (assessed from the above photographs, the above questionnaires and from nurse and doctor led reports of wound breakdown and other complications)

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
480

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

January 29, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

February 8, 2024

Status Verified

January 1, 2024

Enrollment Period

6 months

First QC Date

January 15, 2024

Last Update Submit

January 30, 2024

Conditions

Keywords

hand surgeryhand infectioncomplicationssuture materialscar appearance

Outcome Measures

Primary Outcomes (1)

  • Infection rate %

    Infection rate %

    6-8 weeks

Secondary Outcomes (8)

  • Wound inflammation

    1 week

  • Scar appearance at 1 week

    1 week

  • Patient symptoms at 1 week

    1 week

  • Patient symptoms at 6-8 weeks

    6-8 weeks

  • Hand function at 1 week

    1 week

  • +3 more secondary outcomes

Study Arms (2)

Vicryl rapide suture for Skin closure

ACTIVE COMPARATOR

Skin closure at end of hand trauma surgery

Device: Skin closure at end of hand surgery

Nylon suture for Skin closure

ACTIVE COMPARATOR

Skin closure at end of hand trauma surgery

Device: Skin closure at end of hand surgery

Interventions

skin closure with vicryl rapide suture

Nylon suture for Skin closureVicryl rapide suture for Skin closure

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult emergency hand surgery patients (age 18-100) with suspected bone/tendon/nerve/blood vessel injury or high risk of infection e.g. bites

You may not qualify if:

  • Patients who are unable to consent or do not consent
  • Patients below the age of 18
  • Patients with a known allergy to vicryl rapide (polyglactin 910) or nylon (ethilon) suture.
  • Any patient whose hand surgery requires a skin graft.
  • Any patient operated on as an immediate emergency e.g. amputation, revascularisation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

CellulitisCicatrixSigns and Symptoms

Condition Hierarchy (Ancestors)

Skin Diseases, InfectiousInfectionsSuppurationConnective Tissue DiseasesSkin and Connective Tissue DiseasesInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsFibrosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single centre, parallel, two group, randomised control trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2024

First Posted

February 8, 2024

Study Start

January 29, 2024

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

February 8, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

No plan to share IPD